Cytoflavin in the Rehabilitation of Post-intensive Care Syndrome in Stroke Survivors
Use of Cytoflavin Solution at the Time of Early Rehabilitation in Patients With Post-intensive Care Syndrome Who Underwent Ischemic Stroke
Sponsor: POLYSAN Scientific & Technological Pharmaceutical Company
A observational or N/A phase clinical study on Ischemic Stroke and Post Intensive Care Unit Syndrome, this trial is completed. The trial is conducted by POLYSAN Scientific & Technological Pharmaceutical Company and has accumulated 8 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Aug 2024 — Sep 2024 [monthly]
Completed
-
Jul 2024 — Aug 2024 [monthly]
Completed
-
Feb 2022 — Jul 2024 [monthly]
Completed
Status: Unknown Status → Completed
▶ Show 3 earlier versions
-
Jan 2022 — Feb 2022 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jan 2021 — Jan 2022 [monthly]
Recruiting
-
Jan 2020 — Jan 2021 [monthly]
Recruiting
First recorded
Nov 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- POLYSAN Scientific & Technological Pharmaceutical Company
For direct contact, visit the study record on ClinicalTrials.gov .